Number of people with Parkinson’s dementia in New Zealand
Objective: To estimate the number of people with Parkinson’s disease dementia (PDD) in New Zealand and how this has changed over time. Background: People with…Serum uric acid levels and cognitive function in Parkinson’s disease
Objective: To compare serum uric acid (sUA) levels in Parkinson’s disease (PD) subjects to cognitive function. Background: Reduced sUA levels have been reported in individuals…Relating web-based-visuo-perception to cognition and genetic variability in Parkinson’s disease: interim report
Objective: To relate visuo-perceptual performance with cognitive and genetic measures in Parkinson’s disease. Background: Dementia is a common occurrence in Parkinson’s disease (PD), affecting up…Comparison of Dementia Patients With and Without Parkinson’s Disease Before Dementia-related Psychosis Occurs: An Administrative Claims Data Analysis
Objective: Describe and compare patients with evidence of dementia-related psychosis diagnosed with Parkinson’s disease with dementia (PDD) versus patients with dementia but no Parkinson’s disease…Synaptic function in Parkinson’s disease associated with GBA mutations
Objective: To investigate the pathological substrate of impaired cognition in Parkinson’s disease (PD) associated with glucocerebrosidase (GBA) mutation. Background: Mutations in glucocerebrosidase gene (GBA), originally…Visual hallucinations in Parkinson´s disease and amyloid burden: 18F-Flutemetamol PET-MRI study
Objective: To compare amyloid distribution in patients with Parkinson´s disease (PD) with visual hallucinations (VH-p) and without (VH-n). Background: In patients with PD the prevalence…Comparison of Zonisamide with Non-Levodopa, Anti-Parkinson’s disease Drugs in the Incidence of Parkinson’s Disease-Relevant Symptoms
Objective: This study was to compare zonisamide and other anti-PD drugs by analyzing their associations with the incidence of PD-relevant symptoms. Background: Patients with Parkinson’s…Effects of N-methyl-D-aspartate receptor antagonist in Parkinson’s disease with dementia
Objective: We conducted this longitudinal study to confirm the efficacy of memantine for PDD by analyzing comparative changes in regional cerebral blood flow (rCBF) and…Chitotriosidase is a biomarker for Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)
Objective: ALSP belongs to the large group of rare neurogenetic, adult-onset leukodystrophies. For most of these leukodystrophies, including ALSP, no causative treatment exists. Biomarkers facilitate…Cerebrospinal fluid protein biomarkers in PD patients after DBS-STN surgery: A retrospective analysis of patients that underwent surgery between 1993 and 2001
Objective: To investigate cerebrospinal fluid (CSF) markers of neurodegeneration [neurofilament light chain (NFL), total Tau (T-Tau)], tau pathology [phosphorylated tau (p-Tau)], glial cell damage or…
- « Previous Page
- 1
- …
- 16
- 17
- 18
- 19
- 20
- …
- 33
- Next Page »